» Articles » PMID: 35490179

Deubiquitylase OTUD3 Prevents Parkinson's Disease Through Stabilizing Iron Regulatory Protein 2

Overview
Journal Cell Death Dis
Date 2022 Apr 30
PMID 35490179
Authors
Affiliations
Soon will be listed here.
Abstract

Iron deposits are neuropathological hallmark of Parkinson's disease (PD). Iron regulatory protein 2 (IRP2) is a key factor in regulating brain iron homeostasis. Although two ubiquitin ligases that promote IRP2 degradation have been identified, the deubiquitylase for stabilization of IRP2 in PD remains undefined. Here, we report OTUD3 (OTU domain-containing protein 3) functions as a deubiquitylase for IRP2, interacts with IRP2 in the cytoplasm, de-polyubiquitylates, and stabilizes IRP2 protein in an iron-independent manner. Depletion of OTUD3 results in a disorder of iron metabolism. OTUD3 knockout mice display nigral iron accumulation, motor deficits, and nigrostriatal dopaminergic neurodegeneration, which resembles the pathology of PD. Consistently, decreased levels of OTUD3 are detected in transgenic PD mice expressing A53T mutant of human α-synuclein. Five single nucleotide polymorphism mutations of OTUD3 are present in cases of sporadic PD or controls, although no significant associations of OTUD3 SNPs with sporadic PD are detected. Taken together, these findings demonstrate that OTUD3 is a bona fide deubiquitylase for IRP2 and plays a critical role in the nigral iron deposits in PD.

Citing Articles

Roles of Ubiquitin Ligases and Deubiquitylases in Alzheimer's Disease.

Jia F, Fu L Mol Neurobiol. 2025; .

PMID: 39932514 DOI: 10.1007/s12035-025-04739-2.


Research progress in deubiquitinase OTUD3.

Hou D, Yu D, Yang G, Hu Y, Li H Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025; 49(8):1341-1352.

PMID: 39788523 PMC: 11628234. DOI: 10.11817/j.issn.1672-7347.2024.230581.


The Role and Mechanisms of Ubiquitin-Proteasome System-Mediated Ferroptosis in Neurological Disorders.

Liu X, Wang W, Nie Q, Liu X, Sun L, Ma Q Neurosci Bull. 2025; .

PMID: 39775589 DOI: 10.1007/s12264-024-01343-7.


Integrated network pharmacology and transcriptomics to explore the mechanism of compound Dihuang granule (CDG) protects dopaminergic neurons by regulating the Nrf2/HMOX1 pathway in the 6-OHDA/MPP-induced model of Parkinson's disease.

Sun X, Yang S, He Z, Wang L, He J Chin Med. 2024; 19(1):170.

PMID: 39696456 PMC: 11654441. DOI: 10.1186/s13020-024-01040-7.


Deubiquitinases as novel therapeutic targets for diseases.

Xian Y, Ye J, Tang Y, Zhang N, Peng C, Huang W MedComm (2020). 2024; 5(12):e70036.

PMID: 39678489 PMC: 11645450. DOI: 10.1002/mco2.70036.


References
1.
Trist B, Hare D, Double K . Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease. Aging Cell. 2019; 18(6):e13031. PMC: 6826160. DOI: 10.1111/acel.13031. View

2.
Subramaniam S, Chesselet M . Mitochondrial dysfunction and oxidative stress in Parkinson's disease. Prog Neurobiol. 2013; 106-107:17-32. PMC: 3742021. DOI: 10.1016/j.pneurobio.2013.04.004. View

3.
Kim S, Wong Y, Gao F, Krainc D . Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of Parkinson's disease. Nat Commun. 2021; 12(1):1807. PMC: 7985376. DOI: 10.1038/s41467-021-22113-3. View

4.
Aho V, Houser M, Pereira P, Chang J, Rudi K, Paulin L . Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease. Mol Neurodegener. 2021; 16(1):6. PMC: 7869249. DOI: 10.1186/s13024-021-00427-6. View

5.
Zhu G, Harischandra D, Ghaisas S, Zhang P, Prall W, Huang L . TRIM11 Prevents and Reverses Protein Aggregation and Rescues a Mouse Model of Parkinson's Disease. Cell Rep. 2020; 33(9):108418. PMC: 7906527. DOI: 10.1016/j.celrep.2020.108418. View